Biological bypass in cardiovascular surgery

Thoracic and Cardiovascular Surgeon

Volumn 52, Issue 4, 2004, Pages 237-248

  Lutter, Georg ^a   Quaden, R ^a   Cremer, J ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

Angiogenesis; Arteriogenesis; Blood flow; Collaterals; FGF; Therapeutic angiogenesis; Transmyocardial laser revascularization; VEGF

Indexed keywords

ACIDIC FIBROBLAST GROWTH FACTOR; ADENOVIRUS VECTOR; ANGIOPOIETIN; ANGIOPOIETIN 1; ANGIOPOIETIN 3; ANGIOPOIETIN RECEPTOR; ANTISENSE OLIGODEOXYNUCLEOTIDE; BASIC FIBROBLAST GROWTH FACTOR RECEPTOR; COMPLEMENTARY DNA; CYTOKINE; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; GROWTH FACTOR; LENTIVIRUS VECTOR; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; NAKED DNA; OLIGONUCLEOTIDE; PARVOVIRUS VECTOR; PLASMID DNA; PROSTAGLANDIN DERIVATIVE; RETROVIRUS VECTOR; SCATTER FACTOR; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGINA PECTORIS; ANGIOGENESIS; CAPILLARY FLOW; CARBON DIOXIDE LASER; CARDIOVASCULAR RISK; CARDIOVASCULAR SURGERY; CLINICAL TRIAL; COLLATERAL CIRCULATION; DNA BINDING; DRUG EFFECT; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE THERAPY; GENE TRANSFER; HUMAN; INTENSIVE CARE; ISCHEMIC HEART DISEASE; LIMB ISCHEMIA; LOW LEVEL LASER THERAPY; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; STEM CELL TRANSPLANTATION; VIRAL GENE DELIVERY SYSTEM; VIRUS HYBRID;

ANGIOPOIETINS; CHEMOKINE CCL2; COLLATERAL CIRCULATION; EXTREMITIES; FIBROBLAST GROWTH FACTORS; GENE THERAPY; GROWTH SUBSTANCES; HEPATOCYTE GROWTH FACTOR; HUMANS; ISCHEMIA; MYOCARDIAL ISCHEMIA; MYOCARDIAL REVASCULARIZATION; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; RECEPTORS, GROWTH FACTOR; STEM CELL TRANSPLANTATION; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 4143140814     PISSN: 01716425     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-817843     Document Type: Review

References (127)

1. Ruel M, Sellke FW. Angiogenic protein therapy. Semin Thorac Cardiovasc Surg 2003; 15: 222-235
2. Cohn WE, Ruel M, Zhang JP, Sellke FW, Johnson RG. Internal thoracic artery flow competition: studies in a canine H-graft model. Eur J Cardiothorac Surg 2003; 23: 56-59
3. Ruel M, Wu GF, Khan TA, Voisine P, Bianchi C, Li J, Li J, Laham RJ, Sellke FW. Inhibition of the cardiac angiogenic response to surgical FGF-2 therapy in a swine endothelial dysfunction model. Circulation 2003; 108 (Suppl 1): 11335-340
4. RohenJW, Lütjen-Drecoll E. Zirkulationssystem. In: Rohen JW, Lütjen-Drecoll E (eds). Funktionelle Histologie. Stuttgart: Schattauer, 2000: 147-176
5. Torres Filho IP, Kerger H, Intaglietta M. pO2 measurements in arteriolar networks. Microvasc Res 1996; 51: 202-212
6. Risau W. Mechanisms of angiogenesis. Nature 1997; 386: 671-674
7. Schaper W, Buschmann I. Arteriogenesis, the good and the bad of it. Cardiovasc Res 1999; 43: 835-837
8. Folkman, J. Therapeutic angiogenesis in ischemic limbs. Circulation 1998; 97: 1108-1110
9. Xie Z, Gao M, Batra S, Koyama T. The capillarity of left ventricular tissue of rats subjected to coronary artery occlusion. Cardiovasc Res 1997; 33: 671-676
10. Schaper W. Coronary collateral development: concepts and hypotheses. In: Schaper W, Schaper J (eds). Collateral Circulation. Dortrecht, Norwell: Kluwer Academic Publishers, 1993: 41-64
11. Scholz D, Ito W, Fleming I et al. Ultrastructure and molecular histology of rabbit hind-limb collateral artery growth (arteriogenesis). Virchows Arch 2000; 436: 257-270
12. Zimmermann R, Arras M, Ullmann C et al. Time course of mitosis and collateral growth following coronary microembolization in the porcine heart. Cell Tissue Res 1997; 287: 583-590
13. Lutter G, Martin J, Dern P et al. Evaluation of the indirect revascularization method after 3 months chronic myocardial ischemia. Eur J Cardiothorac Surg 2000; 18: 38-45
14. Takeshita S, Isshiki T, Ochiai M et al. Endothelium-dependent relaxation of collateral microvessels after intramuscular gene transfer of vascular endothelial growth factor in a rat model of hindlimb ischemia. Circulation 1998; 98: 1261-1263
15. Lee SH, Wolf PL, Escudero R, Deutsch R, Jamieson SW, Thistlethwaite PA. Early expression of angiogenesis factors in acute myocardial ischemia and infarction. N Engl J Med 2000; 342: 626-633
16. Hasdai D, Barak V, Leibovitz E et al. Serum basic fibroblast growth factor levels in patients with ischemic heart disease. Int J Cardiol 1997; 59: 133-138
17. Rohovsky S, Kearney M, Pieczek A et al. Elevated levels of basic fibroblast growth factor in patients with limb ischemia. Am Heart J 1996; 132: 1015-1019
18. Fleisch M, Billinger M, Eberli FR, Garachemani AR, Meier B, Seiler C. Physiologically assessed coronary collateral flow and intracoronary growth factor concentrations in patients with 1- to 3-vessel coronary artery disease. Circulation 1999; 100: 1945-1950
19. Mandriota SJ, Pepper MS. Vascular endothelial growth factor-induced in vitro angiogenesis and plasminogen activator expression are dependent on endogenous basic fibrolast growth factor. J Cell Sci 1997; 110: 2293-2302
20. Resnick N, Collins T, Atkinson W, Bonthron DT, Dewey Jr CF, Gimbrone Jr MA. Platelet-derived growth factor B chain promoter contains a cis-acting fluid shear-stress-responsive element. Proc Natl Acad Sci USA 1993; 90: 4591-4595
21. Venema RC, Nishida K, Alexander RW, Harrison DG, Murphy TJ. Organization of the bovine gene encoding the endothelial nitric oxide synthase. Biochem Biophys Acta 1994; 1218: 413-420
22. Li C, Xu Q. Mechanical stress-initiated signal tranductions in vascular smooth muscle cells. Cell Signal 2000; 12: 435
23. Laguens R, Cabeza Meckert P, Crottogini A. Entrance in mitosis of adult cardiomyocytes in ischemic pig hearts after plasmid-mediated rhVEGF165 gene transfer. Gene Ther 2002; 9: 1676-1681
24. Nabel EG, Plautz G, Nabel GJ. Site-specific gene expression in vivo by direct gene transfer into the arterial wall. Science 1990; 249: 1285-1288
25. Lin SJ, Jan KM, Chien S. Temporal and spatial changes in macromolecular uptake in rat thoracic aorta and relation to [3H]thymidine uptake. Atherosclerosis 1990; 85: 229-238
26. Acsadi G, Jiao SS, Jani A, Duke D, Williams P, Chong W, Wolff JA. Direct gene transfer and expression into rat heart in vivo. New Biol 1991; 3: 71-81
27. Jeong JO et al. Improved expression by cytomegalovirus promoter/enhancer and behavior of vascular endothelial growth factor gene after myocardial injection of naked DNA. Exp Mol Med 2002; 34: 278-284
28. Morishita R et al. Recent progress in gene therapy for cardiovascular disease. Circ J 2002; 66: 1077-1086
29. Santiago FS, Khachigian LM. Nucleic acid based strategies as potential therapeutic tools: mechanistic considerations and implications to restenosis. J Mol Med 2001; 79: 695-706 [E-pub Sep 22, 2001]
30. Simons M, Edelman ER, Rosenberg RD. Antisense proliferating cell nuclear antigen oligonucleotides inhibit intimal hyperplasia in a rat carotid artery injury model. J Clin Invest 1994; 93: 2351-2356
31. Zhu NL, Wu L, Liu PX, Gordon EM, Anderson WF, Starnes VA, Hall FL. Downregulation of cyclin G1 expression by retrovirus-mediated anti-sense gene transfer inhibits vascular smooth muscle cell proliferation and neointima formation. Circulation 1997; 96: 628-635
32. Qin L, Pahud DR, Ding Y, Bielinska AU, Kukowska-Latallo JF, Baker JR Jr, Bromberg JS. Efficient transfer of genes into murine cardiac grafts by Starburst polyamidoamine dendrimers. Hum Gene Ther 1998; 9: 553-560
33. Perletti G, Marras E, Dondi D. Assessment of the biological activity of an improved naked-DNA vector for angiogenesis gene therapy on a novel non-mammalian model. Int J Mol Med 2003; 11: 691-696
34. Arsic N, Zentilin L, Zacchigna S. Induction of functional neovascularization by combined VEGF and angiopoietin-1 gene transfer using AAV vectors. Mol Ther 2003; 7: 450-459
35. Harvey BG, Hackett NR, El-Sawy T et al. Variability of human systemic humoral immune responses to adenovirus gene transfer vectors administered to different organs. J Virol 1999; 73: 6729-6742
36. Newman KD, Dunn PF, Owens JW et al. Adenovirus-mediated gene transfer into normal rabbit arteries results in prolonged vascular cell activation, inflammation, and neointimal hyperplasia. J Clin Invest 1995; 96: 2955-2965
37. Eslami MH, Gangadharan SP, Sui XX, Rhynhart KK, Snyder RO, Conte MS. Gene delivery to in situ veins: differential effects of adenovirus and adeno-associated viral vectors. J Vasc Surg 2000; 31: 1149-1159
38. Baumgartner I, Isner J. Somatic gene therapy in the cardiovascular system. Annu Rev Physiol 2001; 63: 427-450
39. Carmeliet P, Ferreira V, Breier G et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 1996; 380: 435-439
40. Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 1999; 13: 9-22
41. Gowdak LHW, Poliakova L, Wang X et al. Adenovirus-mediated VEGF121 gene transfer stimulates angiogenesis in normoperfused skeletal muscle and preserves tissue perfusion after induction of ischemia. Circulation 2000; 102: 565-571
42. Schwarz ER, Speakman MT, Patterson M et al. Evaluation of the effects of intramyocardial injection of DNA expressing vascular endothelial growth factor (VEGF) in a mycardial infarction model in the rat - angiogenesis and angioma formation. J Am Coll Cardiol 2000; 35: 1323-1330
43. Lee RJ, Springer ML, Blanco-Bose WE et al. VEGF gene delivery to myocardium. Deleterious effects of unregulated expression. Circulation 2000; 102: 898-901
44. Eslami MH, Gangadharan SP, Sui XX, Rhynhart KK, Snyder RO, Conte MS. Gene delivery to in situ veins: differential effects of adenovirus and adeno-associated viral vectors. J Vasc Surg 2000; 31: 1149-1159
45. Takeshita S, Tsurumi Y, Couffinahl T et al. Gene transfer of naked DNA encoding for three isoforms of vascular endothelial growth factor stimulates collateral development in vivo. Lab Invest 1996; 75: 487-501
46. Takeshita S, Isshiki T, Ochiai M et al. Endothelium-dependent relaxation of collateral microvessels after intramuscular gene transfer of vascular endothelial growth factor in a rat model of hindlimb ischemia. Circulation 1998; 98: 1261-1263
47. Asahara T, Takahashi T, Matsuda H et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 1999; 18: 3964-3972
48. Baumgartner I, Pieczek A, Manor O et al. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation 1998; 97: 1114-1123
49. Baumgartner I, Rauh G, Pieczek A et al. Lower-extremity edema associated with gene transfer of naked DNA encoding vascular endothelial growth factor. Ann Intern Med 2000; 132: 880-884
50. Thurston G, Rudge JS, Ioffe E et al. Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat Med 2000; 6: 460-463
51. Pepper MS, Vassalli JD, Orci L, Montesano R. Biphasic effect of transforming growth factor-beta 1 on in vitro angiogenesis. Exp Cell Res 1993; 204: 356-363
52. Brogi E, Wu T, Namiki A, Isner JM. Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only. Circulation 1994; 90: 649-652
53. Stavri GT, Hong Y, Zachary IC et al. Hypoxia and platelet-derived growth factor-BB synergistically upregulate the expression of vascular endothelial growth in vascular smooth muscle cells. FEBS Lett 1995; 358: 311-315
54. Khan TA, Sellke FW, Laham RJ. Gene therapy progress and prospects: therapeutic angiogenesis for limb and myocardial ischemia. Gene Ther 2003; 10: 285-291
55. Bianchi R, Rodella L, Rezzani R. Cyclosporine A upregulates expression of matrix metalloproteinase 2 and vascular endothelial growth factor in rat heart. Int Immunopharmacol 2003; 3: 427-433
56. Mehrabi MR et al. Clinical benefit of prostaglandin E1-treatment of patients with ischemic heart disease: stimulation of therapeutic angiogenesis in vital and infarcted myocardium. Biomed Pharmacother 2003; 57: 173-178
57. Symes JF, Losordo DW, Vale PR, Lathi KG, Esakof DD, Mayskiy M, Isner JM. Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease. Ann Thorac Surg 1999; 68: 830-836; discussion 836-837
58. Rivard A, Silver M, Chen D et al. Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF. Am J Pathol 1999; 154: 355-363
59. Waltenberger J, Lange J, Kranz A. Vascular endothelial growth factor-A-induced chemotaxis of monocytes is attenuated in patients with diabetes mellitus. Circulation 2000; 102: 185-190
60. Couffinhal T, Silver M, Kearney M et al. Impaired collateral vessel development associated with reduced expression of vascular endothelial growth factor in ApoE -/- mice. Circulation 1999; 99: 3188-3198
61. Rivard A, Fabre JE, Silver M et al. Age-dependent impairment of angiogenesis. Circulation 1999; 99: 111-120
62. Mignatti P, Morimoto T, Rifkin DB. Basic fibroblast growth factor released by single, isolated cells stimulates their migration in an autocrine manner. Proc Natl Acad Sci USA 1991; 88: 11007-11011
63. Montesano R, Vassalli JD, Baird A, Guillemin R, Orci L. Basic fibroblast growth factor induces angiogenesis in vitro. Proc Natl Acad Sci USA 1986; 83: 7297-7301
64. Speir E, Janner V, Gonzalez AM, Farris J, Baird A, Casscell W. Acidic and basic fibroblast growth factors in adult rat heart myocytes. Localization, regulation in culture, and effects on DNA synthesis. Circ Res 1992; 71: 251-259
65. Sato Y, Rifkin DB. Autocrine activities of basic fibroblast growth factor: regulation of endothelial cell movement, plasminogen activator synthesis, and DNA synthesis. J Cell Biol 1988; 107: 1199-1205
66. Walgenbach KJ, Gratas C, Shestak KC, Becker D. Ischaemia-induced expression of bFGF in normal skeletal muscle: A potential paracrine mechanism for mediating angiogenesis in ischaemic skeletal muscle. Nat Med 1995; 1: 453-459
67. Chen CH, Jiang W, Via DP et al. Oxidized low-density lipoproteins inhibit endothelial cell proliferation by suppressing basic Fibroblast Growth Factor expression. Circulation 2000; 101: 171-177
68. Pepper MS, Ferrara N, Orci L, Montesano R. Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochem Biophys Res Commun 1992; 189: 824-831
69. Safi J Jr, DiPaula AF Jr, Riccioni T et al. Adenovirus-mediated acidic fibroblast growth factor gene transfer induces angiogenesis in the non-ischemic rabbit heart. Microvasc Res 2000; 58: 238-249
70. Heilmann C, von Samson P, Schlegel K, Attmann T, von Specht BU, Beyersdorf F, Lutter G. Comparison of protein with DNA therapy for chronic myocardial ischemia using fibroblast growth factor-2. Eur J Cardiothorac Surg 2002; 22: 957-964
71. Ninomiya M, Koyama H, Miyata T, Hamada H, Miyatake S, Shigematsu H, Takamoto S. Ex vivo gene transfer of basic fibroblast growth factor improves cardiac function and blood flow in a swine chronic myocardial ischemia model. Gene Ther 2003; 10: 1152-1160
72. Schumacher B, Pecher P, von Specht BU, Stegmann T. Induction of neo-angiogenesis in ischemic myocardium by human growth factors. First clinical results of a new treatment of coronary heart disease. Circulation 1998; 97; 645-650
73. Pecher P, Schumacher BA. Angiogenesis in ischemic human myocardium: clinical results after 3 years. Ann Thorac Surg 2000; 69: 1414-1419
74. Kastrup J. Therapeutic angiogenesis in ischemic heart disease: gene or recombinant vascular growth factor protein therapy? Curr Gene Ther 2003; 3: 197-206
75. Goede V, Brogelli L, Ziche M, Augustin HG et al. Induction of inflammatory angiogenesis by monocyte chemoattractant protein-1. Int J Cancer 1999; 82: 765-770
76. Behr TM, Wang X, Aiyar N et al. Monocyte chemoattractant protein-1 is upregulated in rats with volume-overload congestive heart failure. Circulation 2000; 102: 1315-1322
77. Yoshimura T, Yuhki N, Moore SK, Appella E, Lerman MI, Leonard EJ. Human monocyte chemoattractant protein-1 (MCP-1). Full-length cDNA cloning, expression in mitogen-stimulated blood mononuclear leukocytes, and sequence similarity to mouse competence gene JE. FEBS Lett 1989; 244: 487-493
78. Denger S, Jahn L, Wende P et al. Expression of monocyte chemoattractant protein-1 cDNA in vascular smooth muscle cells: induction of the synthetic phenotype: a possible clue to SMC differentiation in the process of atherogenesis. Atherosclerosis 1999; 144: 15-23
79. Schaper W. Coronary collateral development: concepts and hypotheses. In: Schaper W, Schaper J (eds). Collateral Circulation. Dortrecht, Norwell: Kluwer Academic Publishers, 1993: 41 - 64
80. Marumo T, Schini-Kerth VB, Busse R. Vascular endothelial growth factor activates nuclear factor-kappaB and induces monocyte chemoattractant protein-1 in bovine retinal endothelial cells. Diabetes 1999; 48: 1131-1137
81. Wempe F, Lindner V, Augustin HG. Basic fibroblast growth factor (bFGF) regulates the expression of the CC chemokine monocyte chemoattractant protein-1 in autocrine-activated endothelial cells. Arterioscler Thromb Vasc Biol 1997; 17: 2471-2478
82. Ito WD, Arras M, Winkler B, Scholz D, Schaper J, Schaper W. Monocyte chemotactic protein-1 increases collateral and peripheral conductance after femoral artery occlusion. Circ Res 1997; 80: 829-837
83. Heilmann CA, Attmann T, Thiem A, Haffner E, Beyersdorf F, Lutter G. Gene therapy in cardiac surgery: intramyocardial injection of naked plasmid DANN for chronic myocardial ischemia. Eur J Cardiothorac Surg 2003; 24: 785-793
84. Weidner KM, Arakaki N, Hartmann G et al. Evidence for the identity of human scatter factor and human hepatocyte growth factor. PNAS 1991; 88: 7001-7005
85. Grant DS, Kleinman HK, Goldberg ID et al. Scatter factor induces blood vessel formation in vivo. PNAS 1993; 90: 1937-1941
86. Gherardi E, Gray J, Stoker M, Perryman M, Furlong R. Purification of scatter factor, a fibroblast-derived basic protein that modulates epithelial interactions and movement. PNAS 1989; 86: 5844-5848
87. Roletto F, Galvani AP, Cristiani C, Valsasina B, Landonio A, Bertolero F. Basic fibroblast growth factor stimulates hepatocyte growth factor/scatter factor secretion by human mesenchymal cells. J Cell Physiol 1996; 166: 105-111
88. Hayashi S, Morishita R, Nakamura S et al. Potential role of hepatocyte growth factor, a novel angiogenic growth factor, in peripheral arterial disease. Circulation 1999; 100: 11301-11308
89. Morishita R, Nakamura S, Hayashi S et al. Therapeutic angiogenesis induced by human recombinant hepatocyte growth factor in rabbit hind limb ischemia model as cytokine supplement therapy. Hypertension 1999; 33: 1379-1384
90. Aoki M, Morishita R, Taniyama Y et al. Angiogenesis induced by hepatocyte growth factor in non-infarcted myocardium and infarcted myocardium: up-regulation of essential transcription factor for angiogenesis, ets. Gene Therapy 2000; 7: 417-427
91. Suzuki H et al. Hepatocyte growth factor and vascular endothelial growth factor in ischaemic heart disease. Coron Artery Dis 2003; 14: 301-307
92. Li J, Brown LF, Hibberd MG, Grossman JD, Morgan JP, Simons M. VEGF, fik-1, and flt-1 expression in a rat myocardial infarction model of angiogenesis. Am J Physiol 1996; 270: H1803-1811
93. Van Belle E, Witzenbichler B, Chen D et al. Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor. Circulation 1998; 97: 381-390
94. Shyu KG, Manor O, Magner M, Yancopoulos GD, Isner JM. Direct intramuscular injection of plasmid DNA encoding angiopoietin-1 but not angiopoietin-2 augments revascularization in the rabbit ischemic hindlimb. Circulation 1998; 98: 2081-2087
95. Asahara T, Chen D, Takahashi T et al. Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization. Circ Res 1998; 83: 233-240
96. Asahara T, Takahashi T, Matsuda H et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 1999; 18: 3964-3972
97. Valenzuela DM, Griffiths JA, Rojas J et al. Angiopoietins 3 and 4: diverging gene counterparts in mice and humans. PNAS 1999; 96: 1904-1909
98. Li J, Brown LF, Hibberd MG, Grossman JD, Morgan JP, Simons M. VEGF, flk-1, and flt-1 expression in a rat myocardial infarction model of angiogenesis. Am J Physiol 1996; 270: H1803-1811
99. Shen H, Clauss M, Ryan J et al. Characterization of vascular permeability factor/vascular endothelial growth factor receptors on mononuclear phagocytes. Blood 1993; 81: 2767-2773
100. Sharma HS, Wunsch M, Brand T, Verdouw PD, Schaper W. Molecular biology of the coronary vascular and myocardial responses to ischemia. J Cardiovasc Pharmacol 1992; 20: S23-31
101. Chung NA, Makin AJ, Lip GY. Measurement of the soluble angiopoietin receptor tie-2 in patients with coronary artery disease: development and application of an immunoassay. EurJ Clin Invest 2003; 33: 529-535
102. Baumgartner I, Pieczek A, Manor O et al. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation 1998; 97: 1114-1123
103. Frazier OH, March RJ, Horvath KA. Transmyocardial revascularization with a carbon dioxide laser in patients with end-stage coronary artery disease. N Engl J Med 1999; 341: 1021-1028
104. Lutter G, Schwarzkopf J, Lutz C, Martin J, Beyersdorf F. Histologic findings of transmyocardial laser channels after two hours. Ann Thorac Surg 1998; 65: 1437-1439
105. Lutter G, Martin J, Dern P et al. Evaluation of the indirect revascularization method after 3 months chronic myocardial ischemia. Eur J Cardiothorac Surg 2000; 18: 38-45
106. Horvath KA, Chiun E, Maun DC et al. Up-regulation of vascular endothelial growth factor mRNA and angiogenesis after transmyocardial laser revascularization. Ann Thorac Surg 1999; 68: 825-829
107. Pelletier MP, Giaid A, Sivaraman S et al. Angiogenesis and growth factor expression in a model of transmyocadial revascularization. Ann Thorac Surg 1998; 66: 12-18
108. Chiang BB, Roberts AM, Kashem AM et al. Chemoreflexes: an experimental study. Arch Surg 2000; 135: 577-581
109. Morishita R, Nakamura S, Hayashi S et al. Therapeutic angiogenesis induced by human recombinant hepatocyte growth factor in rabbit hind limb ischemia model as cytokine supplement therapy. Hypertension 1999; 33: 1379-1384
110. Asahara T, Chen D, Takahashi Tet al. Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization. Circ Res 1998; 83: 233-240
111. Lutter G, Sarai K, Nitzsche E et al. Evaluation of transmyocardial laser revascularization by following objective parameters of perfusion and ventricular function. Thorac Cardiov Surg 2000; 48: 79-85
112. Valenzuela DM, Griffiths JA, Rojas J et al. Angiopoietins 3 and 4: diverging gene counterparts in mice and humans. PNAS 1999; 96: 1904-1909
113. Tjomsland O, Aaberge L, Almdahl SM et al. Perioperative cardiac function and predictors for adverse events after transmyocardial laser treatment. Ann Thorac Surg 2000; 69: 1098-1103
114. Pelletier MP, Giaid A, Sivaraman S et al. Angiogenesis and growth factor expression in a model of transmyocadial revascularization. Ann Thorac Surg 1998; 66: 12-18
115. Sayeed-Shah U et al. Complete reversal of ischemic wall motion abnormalities by combined use of gene therapy with transmyocardial laser revascularization. J Thorac Cardiovasc Surg 1998; 116: 763-769
116. Hellmann CA, Attmann T, von Samson P, Gobel H, Marme D, Beyersdorf F, Lutter G. Transmyocardial laser revascularization combined with vascular endothelial growth factor 121 (VEGF121) gene therapy for chronic myocardial ischemia - do the effects really add up? Eur J Cardiothorac Surg 2003; 23: 74-80
117. Lutter G, Attmann T, Heilmann C, von Samson P, von Specht B, Beyersdorf F. The combined use of transmyocardial laser revascularization (TMLR) and fibroblastic growth factor (FGF-2) enhances perfusion and regional contractility in chronically ischemic porcine hearts. EurJ Cardiothorac Surg 2002; 22: 753-761
118. + cells identifies a population of functional endothelial precursors. Blood 2000; 95: 952-958
119. Kalka C, Masuda H, Takahashi T et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. PNAS 2000; 97: 3422-3427
120. Kawamoto A, Gwon HC, Iwaguro H, Yamaguchi JI, Uchida S, Masuda H, Silver M, Ma H, Kearney M, Isner JM, Asahara T. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 2001; 103: 634-637
121. Iwaguro H, Yamaguchi J, Kalka C, Murasawa S, Masuda H, Hayashi S, Silver M, Li T, Isner JM, Asahara T. Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration. Circulation 2002; 105: 732-738
122. Pearlman JD, Laham LJ, Simons M. Coronary angiogenesis: detection in vivo with MR imaging sensitive to collateral neocirculation - preliminary study in pigs. Radiology 2000; 214: 801-807
123. Takeshita S, Isshiki T, Mori H et al. Microangiographic assessment of collateral vessel formation following direct gene transfer of vascular endothelial growth factor in rats. Cardiovasc Res 1997; 35: 547-552
124. Beighley PE, Thomas PJ, Jorgensen SM, Ritman EL. 3 D architecture of myocardial microcirculation in intact rat heart: a study with micro-CT. Adv Exp Med Biol 1997; 430: 165-175
125. Mills JD, Fischer D, Villanueva FS. Coronary collateral development during chronic ischemia: serial assessment using harmonic myocardial contrast echocardiography. J Am Coll Cardiol 2000; 36: 618-624
126. Hedman M et al. Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia: phase 11 results of the Kuopio Angiogenesis Trial (KAT). Circulation 2003; 107: 2677-2683
127. Diaz-Sandoval LJ, Losordo DW. Gene therapy for cardiovascular angiogenesis. Expert Opin Biol Ther 2003; 3: 599-616